The oversubscribed round will support final assay development and manufacturing readiness for an early access program launch.

Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI blocking antibody ...

Discover how a unique berry rewires taste perception and explores emerging roles in nutrition, food science, and supportive healthcare ...

Duchenne muscular dystrophy (DMD) is a severe X-linked myopathy characterised by progressive skeletal and cardiac muscle ...

The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments addressing ultrarare diseases. The FDA unveiled draft guidance on a proposed ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Milwaukee charter school Pathways High is expanding to include sixth through eighth grades next fall. Pathways High offers unique classes in subjects like robotics and boat building, often in ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

Evidence Rating Level: 2 (Good) Direct oral anticoagulants (DOACs) and certain antiarrhythmic drugs share CYP3A4 and P-glycoprotein pathways, raising concern that coadministration could increase DOAC ...